Actualités AMAG Pharmaceuticals Inc - AMAG | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing...

WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-211277 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-248825 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-197873 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-159938 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-143272 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-72700 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-182821 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-131656 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-82292 UNITED...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No. 333-168786 UNITED...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AMAG Pharmaceuticals Inc (AMAG)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMAG Actualités

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AMAG Pharmaceuticals Inc (AMAG) Actualités

AMAG Pharmaceuticals Inc (AMAG)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMAG Actualités

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application